WADA's rationale is that BPC-157 is a pharmacological substance not approved for human therapeutic use by any regulatory authority, and its tissue repair properties could provide a performance-enhancing benefit
[1] Always inspect the solution in good light before withdrawing a dose: it should appear clear and free of particles or haze
Peptides Used: 5-Amino-1MQ, SLU-PP-332, Macimorelin, Tesofensine, Tirzepatide Cellular Repair and Healing BPC-157 has been shown to act systemically in the digestive tract to combat conditions like leaky gut, irritable bowel syndrome (IBS), Crohn's disease, and prevent stomach ulcers
Discover its benefits and convenience now
[13] If you're injecting someone else, let them know you're about to inject the supplement